Alopexx Enterprises works with scientists and entrepreneurs to build successful new companies. They invest in novel health care technologies at all stages of development and can serve as a lead investor or collaborate with a group of investors to advance important science. They also have the capabilities to provide management and development expertise where needed. To date, their initial investments have ranged from $1-20M.

Biotechnology

Alopexx Enterprises

Daniel R. Vlock

Peter Honig

Christine De Los Reyes

Thomas T. Thomas

The Board Members at Alopexx Enterprises provide strategic oversight and governance, ensuring the company aligns with its mission to invest in and develop novel health care technologies. They evaluate investment opportunities, set organizational policies, and guide high-level decision-making to drive the success of portfolio companies.

��

Board Members

About

Team members

Other teams at Alopexx Enterprises

Leadership Team

Scientific Advisory Team

��������